Search Results 7441-7450 of 43066 for oral
* Expansion Cohort 11 (HNSCC): Subject with inoperable, refractory, recurrent or metastatic HNSCC of the oral cavity, oropharynx, hypopharynx, and larynx.
Previous experience with an oral or injectable GLP-1 agonist;; Use of the following within 2 weeks of screening: an other GLP-1 agonist, an NK-1 antagonist ...
A doctor inserts a small, flexible tube through your mouth or nose into your lungs to look at your air passages and find the cause of a lung problem.
Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...
Known GI disease or GI procedure that could interfere with oral absorption (including difficulty swallowing) - New York Heart Association (NYHA) Class III ...
... oral cavity primaries regardless of HPV status (per American Joint Committee on Cancer [AJCC] Staging, 8th edition). - Has available archived or fresh core ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Diagnosis · Blood tests. Laboratory tests of blood samples tell your healthcare team more about the M proteins in your body and can show signs of organ damage.
Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.